Kansas Bioscience Authority
13
5M
9
0.76
3
0.31
3
- Stages of investment
- Areas of investment
Summary
In 2004 was created Kansas Bioscience Authority, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Olathe. The fund was located in North America if to be more exact in United States.
The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2013. Opposing the other organizations, this Kansas Bioscience Authority works on 21 percentage points less the average amount of lead investments. Considering the real fund results, this Corporate Investor is 11 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2014.
Among the most popular portfolio startups of the fund, we may highlight Metactive Medical, Flow Forward Medical, Innara Health. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. The fund has exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Kansas Bioscience Authority, startups are often financed by Novartis Venture Fund, Intersouth Partners, MPM Capital. The meaningful sponsors for the fund in investment in the same round are Open Prairie, Middleland Capital, MPM Capital. In the next rounds fund is usually obtained by Serra Ventures, Middleland Capital, Mid-America Angels.
Investments analytics
Analytics
- Total investments
- 13
- Lead investments
- 3
- Exits
- 3
- Rounds per year
- 0.76
- Follow on index
- 0.31
- Investments by industry
- Health Care (11)
- Biotechnology (8)
- Medical (6)
- Medical Device (5)
- Pharmaceutical (4) Show 3 more
- Investments by region
-
- United States (13)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 27M
- Group Appearance index
- 0.62
- Avg. company exit year
- 9
- Avg. multiplicator
- 1.58
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Advanced Animal Diagnostics | 08 Dec 2014 | Biotechnology, Health Diagnostics, Veterinary | Late Stage Venture | 15M | United States, North Carolina |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.